Podcast Episode 4 – Benchmarking Efficiencies, Pre, Peri and Post TAVI Procedure

Tavi podcast series

In the fourth instalment of the TAVI Talk podcast series Interventional Cardiologists Dr. Sagar Doshi from The Queen Elizabeth Hospital, Birmingham and Dr. Charis Costopoulos from Royal Papworth Hospital discuss optimization of the pre, peri and post TAVI procedure.

How can TAVI benefit your low-risk patients with severe aortic stenosis (sAS) now and in the future?

Supported by proven results from PARTNER 3,1 low-risk patients with sAS now have the opportunity for TAVI. As these patients are usually younger and healthier than those in higher risk categories,1-6 further considerations for this group include valve durability and valve-in-valve (ViV) procedures that support their longer-term management.

Podcast Episode 3 – The Collaborative Referral

Tavi podcast series

In the third instalment of the TAVI Talk podcast series, Interventional Cardiologist Dr. Karim Ratib from Royal Stoke University Hospital and Dr. Andrew Epstein, Cardiologist from Wye Valley NHS Trust discuss their Aortic Stenosis Management Service for best patient outcome.

How to avoid the pitfalls of underdiagnosing severe aortic stenosis (sAS)

The characterisation of aortic stenosis (AS) severity remains an ongoing challenge in clinical practice. Patients with discordant echocardiographic indices are commonly described in reports as having less than sAS despite meeting the criteria for sAS. Understanding the limitations of echocardiographic and adopting a step-by-step integrative approach to confirm AS severity can help meet the challenge.1-3

Podcast Episode 2: The Heart Team Approach

Tavi podcast series

In this episode interventional cardiologists and TAVI implanters, Professor Rajesh Kharbanda, Dr Sam Dawkins, Dr Clare Appleby and Dr Joe Mills discuss:

  • The Heart Team approach to patients with Aortic Stenosis
  • the impact of referrals at times of limited resources
  • how a streamlined, efficient TAVI referral pathway can minimise healthcare footprint.

Mortality and treatment delays

Treatment delays in patients with severe aortic stenosis (sAS) continue to impact outcomes. With COVID-19 putting a strain on healthcare resources — and delays in aortic stenosis (AS) treatment carrying a mortality risk that increases the longer the delay — early identification of sAS patients and timely referrals can help minimise these risks.1-3

TAVI under conscious sedation – enabling continuity of treatment for your sAS patients

It remains essential that your severe aortic stenosis (sAS) patients continue to be referred for treatment, however many of them may be anxious about spending time in hospital and need a treatment that offers a shorter hospital stay and quicker return home. TAVI under conscious sedation can offer a range of benefits and address these patient needs.

Content relating to Tavi.today is intended for healthcare professionals. Click OK to confirm you are a healthcare professional and proceed.

Skip to content